Literature DB >> 27249330

Associations Between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis vs Tobacco Users.

Madeline H Meier1, Avshalom Caspi2, Magdalena Cerdá3, Robert J Hancox4, HonaLee Harrington5, Renate Houts5, Richie Poulton6, Sandhya Ramrakha6, W Murray Thomson7, Terrie E Moffitt2.   

Abstract

IMPORTANCE: After major policy changes in the United States, policymakers, health care professionals, and the general public seek information about whether recreational cannabis use is associated with physical health problems later in life.
OBJECTIVE: To test associations between cannabis use over 20 years and a variety of physical health indexes at early midlife. DESIGN, SETTING, AND PARTICIPANTS: Participants belonged to a representative birth cohort of 1037 individuals born in Dunedin, New Zealand, in 1972 and 1973 and followed to age 38 years, with 95% retention (the Dunedin Multidisciplinary Health and Development Study). We tested whether cannabis use from ages 18 to 38 years was associated with physical health at age 38, even after controlling for tobacco use, childhood health, and childhood socioeconomic status. We also tested whether cannabis use from ages 26 to 38 years was associated with within-individual health decline using the same measures of health at both ages. EXPOSURES: We assessed frequency of cannabis use and cannabis dependence at ages 18, 21, 26, 32, and 38 years. MAIN OUTCOMES AND MEASURES: We obtained laboratory measures of physical health (periodontal health, lung function, systemic inflammation, and metabolic health), as well as self-reported physical health, at ages 26 and 38 years.
RESULTS: The 1037 study participants were 51.6% male (n = 535). Of these, 484 had ever used tobacco daily and 675 had ever used cannabis. Cannabis use was associated with poorer periodontal health at age 38 years and within-individual decline in periodontal health from ages 26 to 38 years. For example, cannabis joint-years from ages 18 to 38 years was associated with poorer periodontal health at age 38 years, even after controlling for tobacco pack-years (β = 0.12; 95% CI, 0.05-0.18; P <.001). Additionally, cannabis joint-years from ages 26 to 38 years was associated with poorer periodontal health at age 38 years, even after accounting for periodontal health at age 26 years and tobacco pack-years (β = 0.10; 95% CI, 0.05-0.16; P <.001) However, cannabis use was unrelated to other physical health problems. Unlike cannabis use, tobacco use was associated with worse lung function, systemic inflammation, and metabolic health at age 38 years, as well as within-individual decline in health from ages 26 to 38 years. CONCLUSIONS AND RELEVANCE: Cannabis use for up to 20 years is associated with periodontal disease but is not associated with other physical health problems in early midlife.

Entities:  

Mesh:

Year:  2016        PMID: 27249330      PMCID: PMC4936934          DOI: 10.1001/jamapsychiatry.2016.0637

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  54 in total

1.  Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood.

Authors:  Finn Rasmussen; D Robin Taylor; Erin M Flannery; Jan O Cowan; Justina M Greene; G Peter Herbison; Malcolm R Sears
Journal:  Am J Respir Crit Care Med       Date:  2002-06-01       Impact factor: 21.405

2.  A 10-year prospective study of tobacco smoking and periodontal health.

Authors:  J Bergström; S Eliasson; J Dock
Journal:  J Periodontol       Date:  2000-08       Impact factor: 6.993

Review 3.  Smoking and periodontal disease.

Authors:  D F Kinane; I G Chestnutt
Journal:  Crit Rev Oral Biol Med       Date:  2000

4.  Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Authors:  Louise Arseneault; Mary Cannon; Richie Poulton; Robin Murray; Avshalom Caspi; Terrie E Moffitt
Journal:  BMJ       Date:  2002-11-23

5.  Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.

Authors:  Jean-Pierre Després; Alain Golay; Lars Sjöström
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

6.  Dietary intake and nutritional status of US adult marijuana users: results from the Third National Health and Nutrition Examination Survey.

Authors:  E Smit; C J Crespo
Journal:  Public Health Nutr       Date:  2001-06       Impact factor: 4.022

7.  Triggering myocardial infarction by marijuana.

Authors:  M A Mittleman; R A Lewis; M Maclure; J B Sherwood; J E Muller
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

8.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; J R Gallimore; M B Pepys
Journal:  BMJ       Date:  2000-07-22

9.  Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study.

Authors:  Thomas K Houston; Sharina D Person; Mark J Pletcher; Kiang Liu; Carlos Iribarren; Catarina I Kiefe
Journal:  BMJ       Date:  2006-04-07

10.  Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

Authors:  F Xavier Pi-Sunyer; Louis J Aronne; Hassan M Heshmati; Jeanne Devin; Julio Rosenstock
Journal:  JAMA       Date:  2006-02-15       Impact factor: 56.272

View more
  26 in total

1.  Is marijuana use associated with lower inflammation? Results from waves III and IV of the national longitudinal study of adolescent to adult health.

Authors:  Erin G Ferguson; Zachary L Mannes; Nicole Ennis
Journal:  Drug Alcohol Depend       Date:  2019-02-27       Impact factor: 4.492

2.  The Protective Behavioral Strategies for Marijuana Scale: Further examination using item response theory.

Authors:  Eric R Pedersen; Wenjing Huang; Robert D Dvorak; Mark A Prince; Justin F Hummer
Journal:  Psychol Addict Behav       Date:  2017-07-13

Review 3.  The emerging marijuana retail environment: Key lessons learned from tobacco and alcohol retail research.

Authors:  Carla J Berg; Lisa Henriksen; Patricia A Cavazos-Rehg; Regine Haardoerfer; Bridget Freisthler
Journal:  Addict Behav       Date:  2018-02-01       Impact factor: 3.913

4.  Associations Between Cannabis Use and Cardiometabolic Risk Factors: A Longitudinal Study of Men.

Authors:  Madeline H Meier; Dustin Pardini; Jordan Beardslee; Karen A Matthews
Journal:  Psychosom Med       Date:  2019-04       Impact factor: 4.312

Review 5.  Cannabis for Pain and Headaches: Primer.

Authors:  Philip S Kim; Michael A Fishman
Journal:  Curr Pain Headache Rep       Date:  2017-04

6.  Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016.

Authors:  Magdalena Cerdá; Christine Mauro; Ava Hamilton; Natalie S Levy; Julián Santaella-Tenorio; Deborah Hasin; Melanie M Wall; Katherine M Keyes; Silvia S Martins
Journal:  JAMA Psychiatry       Date:  2020-02-01       Impact factor: 21.596

7.  Oral health implications of increased cannabis use among older adults: Another public health concern?

Authors:  Austin Le; Joseph J Palamar
Journal:  J Subst Use       Date:  2018-08-22

8.  Childhood body mass index and endothelial dysfunction evaluated by peripheral arterial tonometry in early midlife.

Authors:  M J A Williams; B J Milne; A Ambler; R Theodore; S Ramrakha; A Caspi; T E Moffitt; R Poulton
Journal:  Int J Obes (Lond)       Date:  2017-05-03       Impact factor: 5.095

9.  Potential Mechanisms Underlying Marijuana-Associated Periodontal Tissue Destruction.

Authors:  D A Scott; H Dukka; D Saxena
Journal:  J Dent Res       Date:  2021-09-13       Impact factor: 6.116

10.  Smoking, Vaping, and Use of Edibles and Other Forms of Marijuana Among U.S. Adults.

Authors:  Stacey Steigerwald; Peggy O Wong; Beth E Cohen; Julie H Ishida; Marzieh Vali; Erin Madden; Salomeh Keyhani
Journal:  Ann Intern Med       Date:  2018-08-28       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.